Xeris Pharmaceuticals Inc reported $-21735000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acelrx Pharmaceuticals ACRX:US $ -8.15M 0.96M
Acura Pharmaceuticals ACUR:US -282000 154K
Eli Lilly And LLY:US $ 2437.5M 639.8M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
Horizon Pharma HZNP:US $ 439.93M 134.24M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Perrigo Ordinary Shares PRGO:US $ 527.9M 408.9M
Supernus Pharmaceuticals SUPN:US $ 38.61M 2.15M
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M
Zogenix ZGNX:US $ -51.9M 1.17M